Corporate Publications

Grünenthal is a global leader in pain management and related diseases. As a science-based, fully-integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain.

Grünenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America, and the U.S. Our products are available in around 100 countries. In 2022 Grünenthal employed around 4,400 people and achieved revenues of €1.7 bn.

Grünenthal Report 2022/23

Grünenthal Report 2022/23

4,400 dedicated employees – more than 75 years of experience in developing innovative medicines – a fully integrated setup including R&D and five manufacturing sites. These are some of the key figures that have helped us become the leading pain management company in Europe and Latin America.

Our Grünenthal Report provides information about our key objectives and activities, as well as our recent business development highlights and financial performance. Download Full Report PDF

... Annual Report 2022/23 - Shortened Digital Edition
Grünenthal Responsibility Report

Responsibility Report 2022/2023

Our Responsibility Report shares insights into how we conduct our business responsibly, as well as details about our impact on society and the environment. The report offers updates on the goals and KPIs that measure our progress along the value chain. We report in line with the Global Reporting Initiative (GRI) standards and subject our reporting to external auditing.
... Download Responsibility Report 2022/2023 PDF